Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10/10 and 9/10 Unrelated Donor Transplantation
Background: Finding a suitable donor at the optimal time is one of the most challenging issues in many transplant centers. We evaluated the clinical outcomes of 248 patients with acute leukemia and without matched sibling donors (MSD) who underwent alternative transplantation, including haploidentic...
| Published in: | International Journal of Hematology-Oncology and Stem Cell Research |
|---|---|
| Main Authors: | Maryam Barkhordar, Amir Kasaeian, Seied Asadollah Mousavi, Sahar Tavakoli, Mohammad Vaezi, Hosein Kamranzadeh Foumani, Tanaz Bahri, Davood Babakhani, Leila Mirzakhani, Ashraf Mousavi, Ardeshir Ghavamzadeh |
| Format: | Article |
| Language: | English |
| Published: |
Tehran University of Medical Sciences
2021-01-01
|
| Subjects: | |
| Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1427 |
Similar Items
HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis
by: Massimo Berger, et al.
Published: (2022-02-01)
by: Massimo Berger, et al.
Published: (2022-02-01)
Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry
by: Adriana Seber, et al.
Published: (2025-04-01)
by: Adriana Seber, et al.
Published: (2025-04-01)
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
by: Frédéric Baron, et al.
Published: (2023-02-01)
by: Frédéric Baron, et al.
Published: (2023-02-01)
HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis
by: Hiroko Shike, et al.
Published: (2024-12-01)
by: Hiroko Shike, et al.
Published: (2024-12-01)
Who is One Locus Mismatched sibling Donor, Who is not?
by: Mohammadreza Ostadali, et al.
Published: (2009-07-01)
by: Mohammadreza Ostadali, et al.
Published: (2009-07-01)
Who is One Locus Mismatched sibling Donor, Who is not?
by: Mohammadreza Ostadali, et al.
Published: (2009-09-01)
by: Mohammadreza Ostadali, et al.
Published: (2009-09-01)
How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?
by: Ying-Jun Chang, et al.
Published: (2016-04-01)
by: Ying-Jun Chang, et al.
Published: (2016-04-01)
Unrelated donor versus matched sibling donor in adults with acute myeloid leukemia in first relapse: an ALWP-EBMT study
by: Annalisa Ruggeri, et al.
Published: (2016-09-01)
by: Annalisa Ruggeri, et al.
Published: (2016-09-01)
Comparison of Hematopoietic Stem Cell Transplantation Outcomes Using Matched Sibling Donors, Haploidentical Donors, and Immunosuppressive Therapy for Patients With Acquired Aplastic Anemia
by: Yuanfeng Zhang, et al.
Published: (2022-02-01)
by: Yuanfeng Zhang, et al.
Published: (2022-02-01)
5 years DKMS Chile: approach, results and impact of the first unrelated stem cell donor center in Chile
by: Francisco Barriga, et al.
Published: (2023-10-01)
by: Francisco Barriga, et al.
Published: (2023-10-01)
Haploidentical donor is preferred over matched sibling donor for pre-transplantation MRD positive ALL: a phase 3 genetically randomized study
by: Ying-Jun Chang, et al.
Published: (2020-03-01)
by: Ying-Jun Chang, et al.
Published: (2020-03-01)
Human leukocyte antigen-matched unrelated donor search experience for hematological disorder patients requiring transplant: scenario for Indian patients
by: Vikash Chandra Mishra, et al.
Published: (2019-01-01)
by: Vikash Chandra Mishra, et al.
Published: (2019-01-01)
Volunteer unrelated donor cell‐derived acute myeloid leukemia with RUNX1‐RUNX1T1
by: Shinya Hagiwara, et al.
Published: (2021-05-01)
by: Shinya Hagiwara, et al.
Published: (2021-05-01)
Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation
by: Louis Williams, et al.
Published: (2020-04-01)
by: Louis Williams, et al.
Published: (2020-04-01)
The use of haploidentical stem cell transplant as an alternative donor source in patients with decreased access to matched unrelated donors
by: Christopher Graham, et al.
Published: (2024-12-01)
by: Christopher Graham, et al.
Published: (2024-12-01)
Who is the best haploidentical donor for acquired severe aplastic anemia? Experience from a multicenter study
by: Lan-Ping Xu, et al.
Published: (2019-09-01)
by: Lan-Ping Xu, et al.
Published: (2019-09-01)
Desensitization with plasma exchange in a patient with human leukocyte antigen donor-specific antibodies before T-cell-replete haploidentical hematopoietic stem cell transplantation
by: Rasika Dhawan Setia, et al.
Published: (2019-01-01)
by: Rasika Dhawan Setia, et al.
Published: (2019-01-01)
Case report: First report of haploidentical allogeneic hematopoietic stem cell transplantation from donors with mild alpha-thalassemia for acute leukemia
by: Wenshuai Zheng, et al.
Published: (2022-12-01)
by: Wenshuai Zheng, et al.
Published: (2022-12-01)
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donors
by: Eolia Brissot, et al.
Published: (2020-07-01)
by: Eolia Brissot, et al.
Published: (2020-07-01)
The UK kidney donor risk index poorly predicts long-term transplant survival in paediatric kidney transplant recipients
by: Jon Jin Kim, et al.
Published: (2023-06-01)
by: Jon Jin Kim, et al.
Published: (2023-06-01)
Effectiveness of Search for Unrelated Donor of Hematopoietic Stem Cells using Russian System Bone Marrow Donor Search: Experience of RM Gorbacheva Scientific Research Institute of Pediatric Hematology and Transplantation
by: OA Makarenko, et al.
Published: (2017-01-01)
by: OA Makarenko, et al.
Published: (2017-01-01)
Haploidentical related donor vs matched sibling donor allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome aged over 50 years: A single‐center retrospective study
by: Jiafu Huang, et al.
Published: (2020-09-01)
by: Jiafu Huang, et al.
Published: (2020-09-01)
Cellular Immunotherapy: Using Alloreactivity to Induce Anti-Leukemic Responses without Prolonged Persistence of Donor Cells
by: Loren D. Fast, et al.
Published: (2013-11-01)
by: Loren D. Fast, et al.
Published: (2013-11-01)
Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T‐cell lymphoblastic lymphoma
by: Ruowen Wei, et al.
Published: (2023-05-01)
by: Ruowen Wei, et al.
Published: (2023-05-01)
Analysis of the results of allogeneic hematopoietic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair
by: Ye. V. Kuzmich, et al.
Published: (2015-01-01)
by: Ye. V. Kuzmich, et al.
Published: (2015-01-01)
Analysis of the results of allogeneic hematopoietic stem cell transplantation depending on HLA matching of the unrelated donor / recipient pair
by: Ye. V. Kuzmich, et al.
Published: (2015-01-01)
by: Ye. V. Kuzmich, et al.
Published: (2015-01-01)
Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
by: Bhagirathbhai Dholaria, et al.
Published: (2021-05-01)
by: Bhagirathbhai Dholaria, et al.
Published: (2021-05-01)
Comparison of matched sibling donors versus unrelated donors in allogeneic stem cell transplantation for primary refractory acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT
by: Eolia Brissot, et al.
Published: (2017-06-01)
by: Eolia Brissot, et al.
Published: (2017-06-01)
Effects of anti-HLA donor-specific antibodies and desensitization on engraftment of haploidentical hematopoietic stem cell transplantation
by: MA Yao, et al.
Published: (2024-02-01)
by: MA Yao, et al.
Published: (2024-02-01)
Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
by: Yu Zhang, et al.
Published: (2023-01-01)
by: Yu Zhang, et al.
Published: (2023-01-01)
Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study
by: Mojtaba Azari, et al.
Published: (2024-02-01)
by: Mojtaba Azari, et al.
Published: (2024-02-01)
Corrigendum: Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study
by: Mojtaba Azari, et al.
Published: (2024-04-01)
by: Mojtaba Azari, et al.
Published: (2024-04-01)
Donor–Recipient Story in Allogeneic Hematopoietic Stem Cell Transplantation
by: Elena Kum, et al.
Published: (2021-01-01)
by: Elena Kum, et al.
Published: (2021-01-01)
Investigation of KIR/HLA relationship and other clinical variables after T-cell-replete haploidentical bone marrow transplantation in patients with acute myeloid leukemia (AML)
by: Tahereh Bakhtiari, et al.
Published: (2023-06-01)
by: Tahereh Bakhtiari, et al.
Published: (2023-06-01)
IMPACT OF HLA-DPB1 INCOMPATIBILITY ON THE RESULTS OF ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION FROM HLA-A-B-C–DRB1-DQB1-COMPATIBLE UNRELATED DONOR
by: E. G. Khamaganova, et al.
Published: (2018-05-01)
by: E. G. Khamaganova, et al.
Published: (2018-05-01)
Similar outcomes following non-first-degree and first-degree related donor haploidentical hematopoietic cell transplantation for acute leukemia patients in complete remission: a study from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
by: Yishan Ye, et al.
Published: (2023-03-01)
by: Yishan Ye, et al.
Published: (2023-03-01)
Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia
by: Maryam Barkhordar, et al.
Published: (2022-08-01)
by: Maryam Barkhordar, et al.
Published: (2022-08-01)
The Evolution of Hematopoietic Stem Cell Transplantation to Overcome Access Disparities: The Role of NMDP
by: Steven M. Devine
Published: (2024-05-01)
by: Steven M. Devine
Published: (2024-05-01)
Postoperative nursing care of a child with dilated cardiomyopathy of mismatched donor-recipient weight undergoing heart transplantation
by: Fuzhen Ma, et al.
Published: (2023-12-01)
by: Fuzhen Ma, et al.
Published: (2023-12-01)
Haploidentical donor transplant is associated with secondary poor graft function after allogeneic stem cell transplantation: A single‐center retrospective study
by: Wei‐Ran Lv, et al.
Published: (2021-12-01)
by: Wei‐Ran Lv, et al.
Published: (2021-12-01)
Similar Items
-
HSCT with Mismatched Unrelated Donors (MMUD): A Comparison of Different Platforms for GvHD Prophylaxis
by: Massimo Berger, et al.
Published: (2022-02-01) -
Haploidentical, matched-related, and matched-unrelated hematopoietic cell transplant for acute leukemias in the early years of haploidentical transplant implementation in a developing country with a large unrelated donor registry
by: Adriana Seber, et al.
Published: (2025-04-01) -
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMT
by: Frédéric Baron, et al.
Published: (2023-02-01) -
HLA and Non-HLA Factors for Donor Selection in Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide GvHD Prophylaxis
by: Hiroko Shike, et al.
Published: (2024-12-01) -
Who is One Locus Mismatched sibling Donor, Who is not?
by: Mohammadreza Ostadali, et al.
Published: (2009-07-01)
